{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:12:57Z","timestamp":1790179977343,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neubiorev.2023.105439","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:01:28Z","timestamp":1698444088000},"page":"105439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling"],"prefix":"10.1016","volume":"155","author":[{"given":"Katarzyna","family":"Stachowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2023.105439_bib1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41386-020-0644-9","article-title":"Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin","volume":"45","author":"Abdallah","year":"2020","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2014.03.001","article-title":"COX-2-derived endocannabinoid metabolites as novel inflammatory mediators","volume":"35","author":"Alhouayek","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib3","doi-asserted-by":"crossref","DOI":"10.1124\/mol.64.3.570","article-title":"Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail","volume":"64","author":"Andersson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2174\/138955709787847921","article-title":"Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration","volume":"9","author":"Basavarajappa","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neubiorev.2023.105439_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1734-1140(11)70578-3","article-title":"AM251, cannabinoids receptors ligand, improves recognition memory in rats","volume":"63","author":"Bialuk","year":"2011","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.neubiorev.2023.105439_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.02.003","article-title":"The blind men and the elephant: systematic review of systematic reviews of cannabis use related health harms","volume":"33","author":"Campeny","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","article-title":"Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans","volume":"33","author":"Chadwick","year":"2020","journal-title":"Curr. Opin. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mvr.2005.02.001","article-title":"Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium","volume":"69","author":"Chen","year":"2005","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cell.2013.10.042","article-title":"\u03949-THC- caused synaptic and memory impairments are mediated through COX-2 signaling","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2023.105439_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1096\/fj.07-9411com","article-title":"Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury","volume":"22","author":"Choi","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.neubiorev.2023.105439_bib12","article-title":"Unraveling the intoxicating and therapeutic effects of cannabis ingredients on psychosis and cognition","volume":"11","author":"Colizzi","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2215-0366(18)30427-9","article-title":"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomized controlled trial","volume":"6","author":"D\u2019Sousa","year":"2019","journal-title":"Lancet Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signaling and the deteriorating brain.","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/S0029665120000129","article-title":"PUFA and their derivatives in neurotransmission and synapses: a new hallmark of synaptopathies","volume":"79","author":"Di Miceli","year":"2020","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.neubiorev.2023.105439_bib16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-\u03b3.","volume":"16","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/NDT.S2380","article-title":"Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A","volume":"4","author":"Dwivedi","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neubiorev.2023.105439_bib18","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1073\/pnas.1505289112","article-title":"Ribosomal protein S6 kinase 1 signaling in prefrontal cortex controls depressive behavior","volume":"112","author":"Dwyer","year":"2015","journal-title":"Proc. Nat. Acad. Sci., U. S. A"},{"key":"10.1016\/j.neubiorev.2023.105439_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/YIC.0000000000000356","article-title":"Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study","volume":"36","author":"Elnazer","year":"2021","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/mp060066m","article-title":"A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology","volume":"3","author":"Eubanks","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neubiorev.2023.105439_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136953","article-title":"Hippocampal CB1 receptor mediates antidepressant-like effect of synthetic cannabinoid-HU210 in acute despair reaction model in mice","volume":"792","author":"Fang","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2023.105439_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109155","article-title":"Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior","volume":"214","author":"Farinha-Ferreira","year":"2022","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib23","article-title":"Protein interactions and trafficking pathways that regulate the cannabinoid type 1 receptor (CB1R)","volume":"13","author":"Flecher-Jones","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib24","series-title":"Arachidonate Remodeling and Inflammation","author":"Fonteh","year":"2004"},{"key":"10.1016\/j.neubiorev.2023.105439_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.1998.1025","article-title":"Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen","volume":"362","author":"Fowler","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neubiorev.2023.105439_bib26","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1523\/JNEUROSCI.0190-17.2017","article-title":"CB1-dependent long-term depression in ventral tegmental area GABA neurons: a novel target for marijuana","volume":"37","author":"Friend","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14137","article-title":"Cyclooxygenase-2 inhibition reduces stress-induced affective pathology","volume":"5","author":"Gamble-George","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neubiorev.2023.105439_bib28","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/jnr.24934","article-title":"Is cyclooxygenase-1 involved in neuroinflammation?","volume":"99","author":"Ghazanfari","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib29","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2019.10.021","article-title":"Modulation of the inflammatory response benefits treatment-resistant bipolar depression: a randomized clinical trial","volume":"261","author":"Halaris","year":"2020","journal-title":"J. Affect. Dis."},{"key":"10.1016\/j.neubiorev.2023.105439_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13183","article-title":"Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers","volume":"27","author":"Haney","year":"2022","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/brainsci13020325","article-title":"Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review","volume":"13","author":"Hasbi","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib33","article-title":"Biology of cyclooxygenase-2: an application in depression therapeutics","volume":"13","author":"He","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/nn.3480","article-title":"Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation","volume":"16","author":"Hermanson","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archneur.58.3.487","article-title":"Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease","volume":"58","author":"Ho","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s004010000251","article-title":"Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain","volume":"101","author":"Hoozemans","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB1 & CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib38","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB1 cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neubiorev.2023.105439_bib39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","article-title":"Upregulation of CB1 receptors and agonist-stimulated [35S] GTP \u03b3 S binding in the prefrontal cortex of depressed suicide victims","volume":"9","author":"Hungund","year":"2004","journal-title":"Mol. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib40","article-title":"Ketamine-induced antidepressant like effects in mice: a possible involvement of cannabinoid system","volume":"112","author":"Khapkai","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neubiorev.2023.105439_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jnutbio.2014.03.012","article-title":"Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity","volume":"25","author":"Kim","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neubiorev.2023.105439_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2015.01.051","article-title":"Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system","volume":"284","author":"Kruk-Slomka","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib43","series-title":"Heme Peroxdases","first-page":"245","article-title":"The peroxidase and cyclooxygenase activity of prostaglandin H synthase","author":"Kudalkar","year":"2016"},{"key":"10.1016\/j.neubiorev.2023.105439_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn.2736","article-title":"Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal function.","volume":"14","author":"Lafourcade","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1734-1140(09)70025-8","article-title":"Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity","volume":"61","author":"Leite","year":"2009","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neubiorev.2023.105439_bib46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","article-title":"Cannabis and psychiatric disorders: it is not only addiction","volume":"13","author":"Leweke","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib47","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41385-018-0018-3","article-title":"Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses","volume":"11","author":"Lin","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.801234","article-title":"mTORC1 signaling pathway mediates chronic stress-induced synapse loss in the hippocampus","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib49","article-title":"Cannabinoid receptors distribution in mouse cortical plasma membrane compartments","volume":"14","author":"Mahabadi","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neubiorev.2023.105439_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjp.0707651","article-title":"Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells","volume":"153","author":"Malfitano","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.neubiorev.2023.105439_bib51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuron.2016.01.023","article-title":"Cannabinoid control of learning and memory through HCN channels","volume":"89","author":"Maroso","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2023.105439_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbr.2010.01.040","article-title":"The role of TNF-\u03b1 signaling pathway on COX-2 upregulation and cognitive decline induced by \u03b2-amyloid peptide","volume":"209","author":"Medeiros","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113304","article-title":"New insights on nitric oxide: Focus on animal models of schizophrenia","volume":"409","author":"Morales-Medina","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100190","article-title":"Cyclooxygenase-2 inhibition reduces anxiety-like behawior and normalizes enhanced amygdala glutamatergic transmission following chroni\u0107 oral corticosterone treatment.","volume":"11","author":"Morgan","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neubiorev.2023.105439_bib55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbi.2020.07.046","article-title":"Cyclooxygenase-2 inhibition prevents stress induced amygdala activation and anxiety-like behavior","volume":"89","author":"Morgan","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2023.105439_bib56","article-title":"COX-2 inhibitors, aspirin, and other potential anti-inflammatory treatments for psychiatric disorders","volume":"10","author":"Muller","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0028-3908(02)00375-1","article-title":"A role for COX-2 and p38 mitogen activated protein kinase in long-term depression in the rat dentate gyrus in vitro","volume":"44","author":"Murray","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2023.105439_bib58","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/mol.116.104539","article-title":"The multiple waves of cannabinoid 1 receptor signaling","volume":"90","author":"Nogueras-Ortiz","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neubiorev.2023.105439_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2023.105439_bib60","first-page":"11","article-title":"Cannabinoid system and cyclooxygeneses inhibitors","volume":"1","author":"Paunescu","year":"2011","journal-title":"J. Med. Life"},{"key":"10.1016\/j.neubiorev.2023.105439_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","volume":"195","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2023.105439_bib62","first-page":"7353","article-title":"Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefanamic acid. Biochem","volume":"48","author":"Prusakiewicz","year":"2009"},{"key":"10.1016\/j.neubiorev.2023.105439_bib63","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/npp.2014.103","article-title":"The CB1 receptor antagonist AM251 impairs reconsolidation of Pavlovian fear memory in the rat basolateral amygdala","volume":"39","author":"Ratano","year":"2014","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib64","series-title":"Cannabinoids and pain","article-title":"Cannabinoid receptor 1 (CB1)","author":"Rech","year":"2021"},{"key":"10.1016\/j.neubiorev.2023.105439_bib65","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s00429-017-1411-5","article-title":"Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons","author":"Remmers","year":"2017","journal-title":"Brain Struct. Funct"},{"key":"10.1016\/j.neubiorev.2023.105439_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/157340109788185571","article-title":"Dietary manipulations of polyunsaturated fatty acids, the recursors of endocannabinoids, and its implications in human health and disease","volume":"5","author":"Repossi","year":"2009","journal-title":"Curr. Nutr. Food Sci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib67","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neubiorev.2023.105439_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","volume":"26","author":"Ruehle","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib69","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jad.2020.07.074","article-title":"Regulation of cannabinoid CB1 and CB2 receptors, neuroprotective mTOR and pro-apoptotic JNK1\/2 kinases in postmortem prefrontal cortex of subjects with major depressive disorder","volume":"276","author":"Salort","year":"2020","journal-title":"J. Affect. Dis."},{"key":"10.1016\/j.neubiorev.2023.105439_bib70","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1471-4159.2007.04668.x","article-title":"COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity","volume":"102","author":"Sang","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2023.105439_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41401-018-0075-x","article-title":"Brain activity of anandamide: a rewarding bliss?","volume":"40","author":"Scherma","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neubiorev.2023.105439_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2017.00069","article-title":"Endocannabinoids: a promising impact for traumatic brain injury","volume":"8","author":"Schurman","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib73","article-title":"Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neyropsychiatric disorders","volume":"10","author":"Sethi","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.neubiorev.2023.105439_bib74","first-page":"2743","article-title":"Endocannabinoid system: role in depression, recompense, and pain control (Review)","volume":"10","author":"Sharma","year":"2023","journal-title":"J. Surv. Fish. Sci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib75","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/sj.npp.1301343","article-title":"Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia","volume":"32","author":"Smesny","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111961","article-title":"Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 1","volume":"370","author":"Stachowicz","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib77","first-page":"837","article-title":"Application potential of modulation of cyclooxygenase-2 activity: a cognitive approach","volume":"75","author":"Stachowicz","year":"2021","journal-title":"PHMD"},{"key":"10.1016\/j.neubiorev.2023.105439_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114729","article-title":"Deciphering the mechanisms of regulation of an excitatory synapse via cyclooxygenase-2. A review","volume":"192","author":"Stachowicz","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109555","article-title":"The role of polyunsaturated fatty acids in neuronal signaling in depression and cognitive processes","volume":"737","author":"Stachowicz","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neubiorev.2023.105439_bib80","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/FBP.0b013e32830cd839","article-title":"Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission","volume":"19","author":"Stachowicz","year":"2008","journal-title":"Behav. Pharm."},{"key":"10.1016\/j.neubiorev.2023.105439_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135435","article-title":"Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2","volume":"741","author":"Stachowicz","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2023.105439_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105193","article-title":"Upregulation of the mGlu5 receptor and COX-2 protein in the mouse brain after imipramine and NS398, searching for mechanisms of regulation","volume":"150","author":"Stachowicz","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2023.105439_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147660","article-title":"Evidence for the interaction of COX-2 with mGluR5 in the regulation of EAAT1 and EAAT3 protein levels in the mouse hippocampus. The influence of oxidative stress mechanisms","volume":"1771","author":"Stachowicz","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105439_bib84","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.3544-11.2011","article-title":"Synaptic and extrasynaptic NMDA receptors differentialy modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection","volume":"31","author":"Stark","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib85","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2011.01486.x","article-title":"COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation","volume":"164","author":"Straiker","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/fn.2018.74660","article-title":"Interactive involvement of hippocampal cAMP\/PKA and cyclooxygenase-2 signaling pathways in spatial learning in the Morris water maze","volume":"56","author":"Tabrizian","year":"2018","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neubiorev.2023.105439_bib87","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/antiox11102049","article-title":"Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions","volume":"11","author":"Tadijan","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neubiorev.2023.105439_bib88","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neuropharm.2014.06.006","article-title":"The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury","volume":"85","author":"Tchantchou","year":"2014","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.neubiorev.2023.105439_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-018-0086-5","article-title":"Endocannabinoids and related N-acylethanolamines: biological activities and metabolism","volume":"38","author":"Tsuboi","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.neubiorev.2023.105439_bib90","doi-asserted-by":"crossref","first-page":"34","DOI":"10.33393\/dti.2020.2185","article-title":"Interaction of drugs with lipid raft membrane domains as a possible target","volume":"14","author":"Tsuchiya","year":"2020","journal-title":"Drug Target Ins."},{"key":"10.1016\/j.neubiorev.2023.105439_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00693","article-title":"Integrated pathways of COX-2 and mTOR: roles in cell sensing and Alzheimer\u2019s disease","volume":"14","author":"Tyagi","year":"2020","journal-title":"Front Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib92","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transd. Targ. Ther."},{"key":"10.1016\/j.neubiorev.2023.105439_bib93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.prostaglandins.2006.09.009","article-title":"Prostaglandins","volume":"83","author":"Wang","year":"2007","journal-title":"Other Lipids Med."},{"key":"10.1016\/j.neubiorev.2023.105439_bib94","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/biom12060842","article-title":"Influence of inhibition of COX-2-dependent lipid metabolism on regulation of UVB-induced keratinocytes apoptosis by cannabinoids","volume":"12","author":"W\u00f3jcik","year":"2022","journal-title":"Biomolecul"},{"key":"10.1016\/j.neubiorev.2023.105439_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12506","article-title":"Autism-related-behaviors in the cyclooxygenase-2 deficient mouse model","volume":"18","author":"Wong","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2023.105439_bib96","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/brain\/aww117","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice","volume":"139","author":"Woodling","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2023.105439_bib97","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.mcn.2007.12.019","article-title":"COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity","volume":"37","author":"Yang","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105439_bib98","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0197-4580(01)00303-7","article-title":"Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer disease.","volume":"22","author":"Yemakova","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neubiorev.2023.105439_bib99","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41401-018-0051-5","article-title":"Integrating endocannabinoid signaling in the regulation of anxiety and depression","volume":"40","author":"Yin","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"33","key":"10.1016\/j.neubiorev.2023.105439_bib100","doi-asserted-by":"crossref","first-page":"22601","DOI":"10.1074\/jbc.M800524200","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2023.105439_bib101","first-page":"435","article-title":"Role of the endocannabinoid system in the formation and development of depression","volume":"72","author":"Zhou","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.neubiorev.2023.105439_bib102","article-title":"Ketamine promotes the neural differentiation of mouse embryonic stem cells by activating mTOR","author":"Zhou","year":"2020","journal-title":"Mol. Med. Rep."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423004086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423004086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:32:58Z","timestamp":1758969178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763423004086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":102,"alternative-id":["S0149763423004086"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105439","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105439"}}